[Interaction between human serum albumin and thromboxane A2 synthetase inhibitors (OKY-1580 and OKY-046)].
D000179:Acrylates / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D001665:Binding Sites; D004347:Drug Interactions; D006801:Humans; D008689:Methacrylates / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D011485:Protein Binding; D012709:Serum Albumin / Q000378:metabolism*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
D000179:Acrylates; D008689:Methacrylates; D012709:Serum Albumin; C031517:2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid; D013930:Thromboxane-A Synthase; C034364:ozagrel